Cargando...
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitaglip...
Gardado en:
| Publicado en: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720914/ https://ncbi.nlm.nih.gov/pubmed/31444259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228981 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|